Benchmark Holdings plc (AIM: BMK, Euronext Growth Oslo: BMK), the aquaculture
biotechnology business, will announce its Q1 results, for the three month period
ended 31 December 2022, on Tuesday 28 February 2023.
Presentation for analysts and investors at 9 am CET
Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial
Officer will host an in-person presentation for analysts and institutional
investors on the day at 9.00 am CET/8.00 am UK time in Oslo, Norway. The
presentation will take place at Hotel Continental, Stortingsgata 24/26, 0117
Oslo.
A live webcast of the presentation is available for analysts and investors to
join remotely at the following link:
https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20230228_7
For further details, and to register your interest, please contact
benchmark@mhpgroup.com.
Equity Development webcast on Wednesday 1 March at 12 pm UK time
Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial
Officer will host a second webcast for retail investors and wealth managers on
Wednesday 1 March at 13.00 pm CET/12.00 pm UK time. The webcast is open to all
existing and potential shareholders.
To register please visit:
https://www.equitydevelopment.co.uk/news-and-events/benchmark-q1results-presenta
tion-1march2023
A recording of the presentation will be available after the event on the Equity
Development website.
Enquiries
For further information, please contact:
Benchmark Holdings plc Tel: 0114 240 9939
Trond Williksen, CEO
Septima Maguire, CFO
Ivonne Cantu, Investor Relations
Numis (Broker and NOMAD) Tel: 020 7260 1000
James Black, Freddie Barnfield, Duncan Monteith
MHP Tel: 020 3128 8004
Katie Hunt, Reg Hoare, Veronica Farah benchmark@mhpgroup.com
Equity Development
Hannah Crowe
Tel: 020 7065 2692
About Benchmark
Benchmark is a leading aquaculture biotechnology company. Benchmark's mission is
to enable aquaculture producers to improve their sustainability and
profitability.
We bring together biology and technology to develop innovative products and
solutions which improve yield, quality and animal health and welfare for our
customers. We do this by improving the genetic make-up, health and nutrition of
their stock - from broodstock and hatchery through to nursery and grow out.
Benchmark has a broad portfolio of products and solutions, including salmon
eggs, live feed (Artemia), specialist diets and probiotics and sea lice
treatments. Find out more at www.benchmarkplc.com.